Search

Your search keyword '"Yannoukakos, Drakoulis"' showing total 797 results

Search Constraints

Start Over You searched for: Author "Yannoukakos, Drakoulis" Remove constraint Author: "Yannoukakos, Drakoulis"
797 results on '"Yannoukakos, Drakoulis"'

Search Results

51. Publisher Correction: Shared heritability and functional enrichment across six solid cancers

52. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

53. Shared heritability and functional enrichment across six solid cancers

55. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

56. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

57. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

58. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

59. Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

60. Physical activity, sedentary time and breast cancer risk : a Mendelian randomisation study

61. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

62. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

63. Physical activity, sedentary time and breast cancer risk:a Mendelian randomisation study

64. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

65. Identifying and testing for hereditary susceptibility to breast/ovarian cancer in Serbia: Where are we now?

66. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

69. Supplement to: Breast-cancer risk in families with mutations in PALB2.

71. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

72. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

73. CanVaS: Documenting the genetic variation spectrum of Greek cancer patients

74. Author Correction : A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

75. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers.

76. Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study

77. International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation

79. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

80. Breast-Cancer Risk in Families with Mutations in PALB2

81. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium

83. Re‐evaluating the pathogenicity of the c.783+2T>C BAP1 germline variant

84. Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients

85. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

86. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

87. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

88. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

89. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

90. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

92. BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects

93. Abstract P6-08-33: A remarkably high yield of identified hereditary breast cancer cases in a single oncology center, followed by inversely proportional rate of cascade testing in family relatives

94. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

95. A Mendelian randomization analysis of circulating lipid traits and breast cancer risk

97. Genetically predicted DNA methylation biomarkers and epithelial ovarian cancer risk: data from nearly 63,000 women of European descent

98. Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

99. Prevalence and founder effect of the BRCA1 p.(Val1833Met) variant in the Greek population, with further evidence for pathogenicity and risk modification

100. A Patient Affected with Serous Ovarian/Peritoneal Carcinoma Carrying the FANCM Mutation

Catalog

Books, media, physical & digital resources